Biotech | September 17, 2021
Argenta acquires Klifovet to expand global footprint in animal health
Klifovet’s client base comprises the world’s top animal health and nutrition companies as well as many promising startups
Klifovet’s client base comprises the world’s top animal health and nutrition companies as well as many promising startups
The global CRAMS segment is expected to clock 6.2% CAGR over CY21-26E to touch US $ 170 billion
The bioequivalence study was conducted by Accutest Research India, one of the preferred CRO players in India
The value of the contract is estimated to be between Rs 20-30 crores per year for the next three years
In the last two years, Sai Life Sciences has made significant investments and progress in advancing its sustainability agenda as part of its organizational transformation initiative
Domestic business was up 41.9% YoY and 27.7% QoQ
The company's discovery services support a wide range of global innovator companies from start-ups to large pharma companies, across a diverse set of therapeutic areas including oncology, CNS, antivirals, and inflammation among others
The company is doubling its chemistry research capacity that should commission by Q2'FY22
The progress has been encouraging with approvals and launches in the US, EU, Japan, Australia and Emerging Markets. Post Mylan Upjohn (Pfizer) merger, the scope has been extended to China as well.
Subscribe To Our Newsletter & Stay Updated
